Development of supportive management to prevent docetaxel-induced peripheral neuropathy with compression therapy.

Phase 2

• Conditions: breast cancer; Breast cancer, chemotherapy, peripheral neuropathy; D001943

• Registration Number: JPRN-jRCTs072180038
• Lead Sponsor: Eguchi Susumu

Brief Summary

In this study, the efficacy of compression therapy using sleeves and stockings to prevent PN induced by doce taxel was not demonstrated.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-03-13
• Study Completion: 2021-03-31
• Results First Posted: 2022-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 84

Inclusion Criteria

Patients who is going to have chemotherapy (docetaxel)

Exclusion Criteria

Patients who have peripheral neuropathy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of all grade peripheral neuropathy

Secondary Outcome Measures

Name	Time	Method
Incidence of peripheral neuropathy according grade, Incidence of peripheral neuropathy in each course of docetaxel, Completion rates of compression therapy, Safety of compression therapy, Relative dose intensity